Cite
HARVARD Citation
Musella, A. et al. (2018). Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer. Cancer treatment reviews. pp. 7-14. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Musella, A. et al. (2018). Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer. Cancer treatment reviews. pp. 7-14. [Online].